Cat.#: ACPP-1305
| Despition | Aph 1b Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1688 | Human CDK1 Protein, Sf9 (AC1688) | 2 µg | inquiry |
| ACPP-1111 | Recombinant Human NRG1 Protein (Fc Tag) (AC1111) | 50 µg | inquiry |
| ACPP-1692 | Human GLUL Protein (AC1692) | 5 µg | inquiry |
| ACPP-1293 | TORC2 Blocking Peptide (AC1293) | 250 µg | inquiry |
| ACPP-1187 | 5HT1A Blocking Peptide (AC1187) | 250 µg | inquiry |
| ACPP-1240 | PAX5 Blocking Peptide (AC1240) | 250 µg | inquiry |
| ACPP-1770 | Human AHSG Protein (AC1770) | 2 µg | inquiry |
| ACPP-1475 | Human MT3 Protein (AC1475) | 2 µg | inquiry |
| ACPP-1433 | Human Interleukin 6 (Active) Protein (AC1433) | 100 µg | inquiry |
| ACPP-1129 | Recombinant Human GLP-1R Protein (Fc Tag) (AC1129) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.